We’ve never been more aware of where our pharmaceuticals and medical products come from, or how long therapeutics take to develop from research to product. Michael Cunningham, National Head of Life Sciences is joined by Dr Dan Grant, Managing Director and CEO of MTPConnect, Australia’s industry growth centre for the medical technology and pharmaceutical sector. They explore the opportunities outlined in the Government’s Medical Products Roadmap. Supporting the sector needs more than just funding. Competition and hurdles ahead for our burgeoning life sciences sector include the war for talent and access for funding. But what an opportunity ahead of us to not only innovate and grow this critical sector but to improve health outcomes for patients here and overseas. The legacy of COVID will be a stronger life sciences sector.